Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Press South Dakota.
Press releases published on August 14, 2025
ModelOp Launches Good Decisions, a New Podcast About Human Decision Making in the Age of AI
GlobeNewswire
·
August 14, 2025
CHICAGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leading AI lifecycle automation and governance software for enterprises, announced today the launch of its new podcast Good Decisions. From CIA officers turned CTOs to tech pioneers and data …
Healthcare Innovation Summit Africa Returns to Johannesburg - Registration Now Open
GlobeNewswire
·
August 14, 2025
JOHANNESBURG, South Africa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Healthcare Innovation Summit Africa (HISA) 2025, Africa’s leading platform for exploring the latest trends and technologies shaping the healthcare industry, will return to Johannesburg on 22 …
CoreCard Corporation Reports Second Quarter 2025 Results
GlobeNewswire
·
August 14, 2025
NORCROSS, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, …
Avicanna Reports Q2 2025
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Evaxion announces business update and second quarter 2025 financial results
GlobeNewswire
·
August 14, 2025
COPENHAGEN, Denmark, August 14, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces second quarter 2025 financial results. …
Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference
GlobeNewswire
·
August 14, 2025
CNSide® can quantify leptomeningeal metastases (LM) over time and monitor changes in the expression of multiple targetable mutations CNSide® may catalyze LM treatment initiation, allow physicians to adapt treatment with real time shifts in tumor biology, …
nCino Announces Timing of its Second Quarter Fiscal Year 2026 Financial Results Conference Call
GlobeNewswire
·
August 14, 2025
WILMINGTON, N.C., Aug. 14, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will report financial results for its second quarter ended July 31, 2025, after the market close on …
Xtract One Drives International Growth Through US$2.6 Million Follow-On Contract with Global Entertainment Organization
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced it has been awarded a US$2.6 million contract to expand its SmartGateway deployment at a major …
Cassava Reports Q2 2025 Financials Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsy Recent appointment of experienced neuroscience leaders to guide the clinical …
Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
August 14, 2025
- Received FDA approval for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB) - - U.S. launch on …
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
Announced updated Phase 2 data at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, demonstrating deep and durable responses and a meaningfully differentiated safety and tolerability profile for an anti-CTLA-4 combination therapy On track …
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
August 14, 2025
Breakthrough Therapy designation granted for LX2006 based on interim data from Phase I/II trials demonstrating clinically meaningful improvements in cardiac and neurologic measures of Friedreich ataxia LX2006 selected for FDA Chemistry, Manufacturing, and …
3 E Network Announces Strategic Intent to Seize Opportunities in the New Compliance-Driven Stablecoin Era
GlobeNewswire
·
August 14, 2025
Hong Kong, China, Aug. 14, 2025 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider, today announced its strategic …
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
GlobeNewswire
·
August 14, 2025
Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million at the end of Q2, Increased from $8.4 Million in Q1 …
Jonathan Low Named Forbes 40 Under 40 for Tech Innovation and Global Finance Impact
GlobeNewswire
·
August 14, 2025
Dubai, UAE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Jonathan Low, founder of Biptap and a driving force in global finance, fintech, and Web3, has earned a spot on Forbes’ prestigious 40 Under 40 list in Tech. This honor cements his reputation as a visionary …
DogWalker Announces DOGWALK Token Pre-Sale, Transforming Blockchain Pet Care
GlobeNewswire
·
August 14, 2025
Marbella, Spain, Aug. 14, 2025 (GLOBE NEWSWIRE) -- DogWalker has officially launched the pre-sale of the DOGWALK Token (DWT). The project describes itself as the first fully blockchain-integrated dog walking and pet care ecosystem. Built for real-world …
Cellectar Biosciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
August 14, 2025
Intend to Pursue an NDA Submission to the U.S. FDA under Accelerated Approval Pathway for Iopofosine I 131 for the Treatment of Waldenstrom Macroglobulinemia (WM) Subject to Sufficient Funding and Once the Confirmatory Trial is Underway Continue to Work …
reAlpha Tech Corp. Announces 1,909% Year-over-Year Revenue Growth for Quarter Ended June 30, 2025
GlobeNewswire
·
August 14, 2025
DUBLIN, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced financial results and business highlights for the quarter ended June 30, 2025. …
EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation
GlobeNewswire
·
August 14, 2025
First Program from EVOLVE T-Cell Engager Platform to Advance into Clinical Development Phase 1 Clinical Trial of EVOLVE104 to be Initiated in 2025 BRANFORD, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company …
MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Continues to Enroll Patients NexoBrid® Manufacturing Expansion on Track; Full Operational Capacity Expected by Year-End 2025 Additional Strategic Research Collaborations Established with Essity and …